AffiAB® Anti-TNS4 Antibody [PD00-95]
TNS4, as the others tensins, contains a phosphotyrosine-binding domain (PTB) , which plays the role of interacting with the cytoplasmic tail of the β-integrin. Also TNS4 is found to play a central role in HGF-induced tubulogenesis. The role of TNS4 on cell proliferation is found to be minimal and not up to the level of the effect of migration. By enhancing the motility and having the effect on the tubulogenesis, TNS4 is believed to have a role in cancer cell metastasis. The role of cten in cancer is not well defined. In prostate cancer it is down-regulated, where in normal cells it is localized to focal adhesions recruiting the tumour suppressor, deleted in liver cancer (DLC-1) , thus suppressing tumorigenesis. Cten in prostate epithelial cells has also been found to regulate staurosporine-induced apoptosis where cten is cleaved by caspase 3 and results in reduction in cell growth rate. Therefore, loss of cten expression may lead to uncontrolled cell growth and result in cell transformation. Accordingly, in prostate cancer, cten may function as a tumour suppressor protein.
Antibody type
Recombinant Rabbit monoclonal Antibody
Uniprot ID
SwissProt: Q8IZW8 Human
Recombinant
YES
Conjugation
Non-conjugated
Host
Rabbit
Isotype
IgG
Clone
PD00-95
KO/KD
N/A
Species reactivity
Human
Tested applications
IHC-P
Predicted species reactivity
N/A
Immunogen
Synthetic peptide within Human TNS4/CTEN aa 700 to the C-terminus (C terminal) .
Storage
Store at +4°C after thawing. Aliquot store at -20°C. Avoid repeated freeze / thaw cycles.
Form
Liquid
Storage buffer
PBS (pH7.4) , 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration
1 mg/mL.
Purity
Protein A affinity purified.
Signal pathway
N/A
Recommended dilutions
IHC-P: 1:500
Molecular Weight
Predicted band size: 77 kDa
Subcellular location
Cell junction, focal adhesion, Cytoplasm, cytoskeleton.
Positive control
Human liver carcinoma tissue, human placenta tissue.